Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$217M |
| 2 |
JPMorgan Chase
JPM
|
+$213M |
| 3 |
Intel
INTC
|
+$200M |
| 4 |
FISV
Fiserv Inc
FISV
|
+$184M |
| 5 |
TECD
Tech Data Corp
TECD
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$685M |
| 2 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$127M |
| 3 |
Meta Platforms (Facebook)
META
|
+$122M |
| 4 |
Merck
MRK
|
+$110M |
| 5 |
NVIDIA
NVDA
|
+$108M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 9.01% |
| 2 | Technology | 7.75% |
| 3 | Financials | 7.01% |
| 4 | Consumer Discretionary | 6.9% |
| 5 | Industrials | 6.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BFIN
3901
DELISTED
BankFinancial
BFIN
| $117K | ﹤0.01% |
+13,982
| New | +$112K |
|
|
CRON
3902
Cronos Group
CRON
$1.26B
| $117K | ﹤0.01% |
+19,481
| New | +$119K |
|
|
TEF
3903
DELISTED
Telefonica
TEF
| $116K | ﹤0.01% |
28,563
+14,083
| +97% | +$54.6K |
|
|
GSB
3904
DELISTED
GlobalSCAPE, Inc.
GSB
| $116K | ﹤0.01% |
11,896
-120,696
| -91% | -$1.12M |
|
3905
Beazer Homes USA
BZH
$883M
| $115K | ﹤0.01% |
11,415
-585,849
| -98% | -$4.68M |
|
|
CNR
3906
Core Natural Resources Inc
CNR
$4.78B
| $115K | ﹤0.01% |
+22,723
| New | +$142K |
|
|
TFFP
3907
DELISTED
TFF Pharmaceuticals, Inc. Common Stock
TFFP
| $115K | ﹤0.01% |
796
-1,435
| -64% | -$181K |
|
|
KWY
3908
Kingsway Corp
KWY
$308M
| $114K | ﹤0.01% |
50,801
-9,258
| -15% | -$18.4K |
|
3909
Viper Energy
VNOM
$16.1B
| $113K | ﹤0.01% |
+10,872
| New | +$104K |
|
3910
Jerash Holdings
JRSH
$71.4M
| $111K | ﹤0.01% |
22,801
+85
| +0.4% | +$402 |
|
|
VCNX
3911
DELISTED
Vaccinex, Inc. Common Stock
VCNX
| $111K | ﹤0.01% |
147
-65
| -31% | -$50.7K |
|
|
RUHN
3912
DELISTED
Ruhnn Holding Limited American Depositary Shares
RUHN
| $111K | ﹤0.01% |
37,372
-251
| -0.7% | -$858 |
|
3913
Fidelity MSCI Energy Index ETF
FENY
$2.13B
| $110K | ﹤0.01% |
+11,107
| New | +$108K |
|
3914
IDT Corp
IDT
$1.7B
| $110K | ﹤0.01% |
+16,788
| New | +$98.9K |
|
3915
First Bank
FRBA
$449M
| $109K | ﹤0.01% |
+16,768
| New | +$119K |
|
3916
J. Jill
JILL
$299M
| $109K | ﹤0.01% |
+31,615
| New | +$85.7K |
|
|
JNCE
3917
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $109K | ﹤0.01% |
15,745
-50,381
| -76% | -$272K |
|
|
RNWK
3918
DELISTED
RealNetworks Inc
RNWK
| $108K | ﹤0.01% |
83,000
-90,755
| -52% | -$99.5K |
|
|
ATXS
3919
DELISTED
Astria Therapeutics
ATXS
| $107K | ﹤0.01% |
+2,771
| New | +$98.7K |
|
3920
Cleveland-Cliffs
CLF
$6.45B
| $107K | ﹤0.01% |
19,356
-483,516
| -96% | -$2.35M |
|
|
SVBI
3921
DELISTED
Severn Bancorp Inc/MD
SVBI
| $107K | ﹤0.01% |
+16,443
| New | +$97.4K |
|
3922
MediciNova
MNOV
$75.3M
| $106K | ﹤0.01% |
19,466
-16,035
| -45% | -$85K |
|
|
RESN
3923
DELISTED
Resonant Inc.
RESN
| $105K | ﹤0.01% |
44,885
-21,477
| -32% | -$47.7K |
|
|
CHAP
3924
DELISTED
Chaparral Energy, Inc.
CHAP
| $104K | ﹤0.01% |
+160,360
| New | +$84.4K |
|
3925
Ascent Industries
ACNT
$134M
| $101K | ﹤0.01% |
+13,531
| New | +$118K |
|
Similar funds
Israel Englander's Q2 2020 Portfolio in Review
As of Q2 2020, Israel Englander held 4,914 positions worth $73B, up 64% from $44.5B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Israel Englander deployed $17.6B of net new capital in Q2 2020, opening 1,140 new positions and adding to 1,565 existing holdings. Its largest new stake was Global Payments: 1,008,446 shares worth $171M.
By sector, the portfolio is most concentrated in Healthcare at 9% of assets, down from 12% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was iShares 1-5 Year Investment Grade Corporate Bond ETF, an estimated $127M trimmed.
- Israel Englander's largest Q2 2020 buy was Global Payments: 1,008,446 shares worth $171M.
- Israel Englander added most to Lowe's Companies in Q2 2020, an estimated $217M increase.
- Israel Englander's biggest Q2 2020 reduction was iShares 1-5 Year Investment Grade Corporate Bond ETF, cutting an estimated $127M.
- Israel Englander fully exited Allergan plc in Q2 2020, selling an estimated $685M.
- Israel Englander's ten largest holdings make up 20% of its $73B portfolio in Q2 2020.
- Israel Englander opened 1,140 new positions and closed 798 in Q2 2020.
- Israel Englander's portfolio value rose 64% quarter-over-quarter to $73B.
Based on Millennium Management's 13F filing for Q2 2020, filed 14 Aug 2020.